Maribavir is a benzimidazole riboside with activity against cytomegalovirus (CMV). The safety and efficacy of maribavir for preemptive treatment of CMV infection in transplant recipients is not known. Design adds clarity. Using colour, typo graphy, hierarchy, contrast, and all the other tools at their disposal, designers can take an unordered jumble of… In a phase… Continuar leyendo Maribavir for Preemptive Treatment
Diabetes might be more deadly for women than men, at least when it comes to heart troubles, new research shows. Heart disease occurs an average of 15 years earlier in people with diabetes, and is their main cause of illness and death. In women, the connection between diabetes and heart disease is particularly strong. Worldwide,… Continuar leyendo Diabetes Tougher on Women’s Hearts
Here’s some worrisome news for folks who manage to survive a heart attack: New research suggests they might be far more vulnerable to developing cancer down the road. People who suffered a heart health scare — a heart attack, heart failure or a dangerously erratic heart rhythm — had a more than sevenfold increased risk… Continuar leyendo Cancer Risk May Rise After Heart Attack
Introduction: Venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE), is the third most common cardiovascular disease and, globally, more than an estimated 10 million people have it yearly. It is a chronic and recurrent disease. The symptoms of VTE are non‐specific and the diagnosis should actively be sought once considered. The mainstay… Continuar leyendo New guidelines from the Thrombosis
Input your search keywords and press Enter.